SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Teslas rocket-thruster Roadster demonstration drove intense discussion, but traders largely framed the sharp reversal after an initial pop as a sell the news reaction, questioning the cars practicality and near-term earnings impact. Some see the demo as an impressive technology showcase and speculate it could strengthen a TeslaSpaceX merger case, though no merger has been announced; broader weakness in tech stocks also weighed on shares.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is caught in a broader semiconductor selloff as investors question the sustainability and financing of AI spending; traders also cite CEO Hock Tans comments about capital constraints and speculative AI investing as adding to the pressure. The community is split between bearish concerns about AI demand and the remarks impact, and bulls who see the decline as a sector-wide pullback and continue to buy on weakness.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp, high-volume selloff with no reported company-specific news has focused discussion on suspected options-expiration pressure near the $10 strike and weakness across biotech stocks. Traders remain focused on the delayed 80th-event update and eventual Phase 3 REGAL data, with bullish dip-buyers viewing the decline as technical while skeptics cite the prolonged quiet period and uncertainty around the trial.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

SMCIs steep selloff amid a broader AI-infrastructure pullback is driving attention, with traders debating whether sector weakness and lingering governance and export-control concerns outweigh the appointment of new CFO Mark Long. Some view the decline as an overdone buying opportunity, while others expect further weakness and question managements credibility.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. It operates through the Hard Disk Drives (HDD) segment. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digitals steep decline is being discussed amid a broader storage and AI-hardware selloff, with traders citing Toshibas planned HDD capacity expansion and Wells Fargos price-target cut as sources of pressure. Some see the concerns as overblown given AI-driven storage demand and upcoming earnings, while others point to continued selling and weak technical momentum.

Tidal Trust II - YieldMax Semiconductor Portfolio Option Income ETF

YieldMax Semiconductor Portfolio Option Income ETF

CHPY is drawing attention amid a semiconductor and technology selloff, with traders linking its decline to weakness in chip stocks and concerns about the AI trade. Some investors are buying the dip for the ETFs weekly distributions, while others question payout sustainability and warn that falling semiconductor prices can pressure its share value.

ProShares Trust II - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

UVXYs sharp gain has sparked bets on a broader volatility spike, with traders pointing to market weakness and concerns about rates, oil, and geopolitical risks. Views are divided: some expect volatility to climb further, while others see a short-lived pop and cite the ETFs futures exposure and decay as reasons to fade rallies.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

OUST is drawing attention after a sharp pullback alongside weakness in AI and growth stocks, with traders debating whether the decline is an overreaction or a sign of further downside. Many are buying or averaging down, while others point to the stocks volatile trading and weakening chart.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bull 3X ETF

Direxion Daily S&P Biotech Bull 3X Shares

A sharp pullback in biotech stocks, reflected in weakness across the XBI, is driving attention to LABU, whose 3 leverage magnifies sector moves. Traders debate whether the declineoften linked in the discussion to inflation and higher-rate concernsis a buying opportunity or the start of further losses, with some favoring LABD or short trades.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X ETF

Direxion Daily S&P Biotech Bear 3X Shares

LABDs gain is drawing attention as traders position for further biotech weakness, citing XBIs decline and concerns that hot inflation data and higher rates could pressure the sector. The bearish view is contested by traders expecting a biotech rebound, with many emphasizing the sharp swings and decay risk of the leveraged inverse ETF.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Palvella Therapeutics is Now Oversold (PVLA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which me...

Niagen Bioscience Engages Veteran Pharmaceutical Executives and Biotechnology Experts to Support Drug Development Program and Strategic Business Growth

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, announces today that its wholly owned subsidiary, NAD Pharmaceuticals Corp., has engaged Red Sky Partners, a life sciences strategic advisory firm...

Full Transcript: Palvella Therapeutics Q2 2026 Earnings Call

Palvella Therapeutics (NASDAQ:PVLA) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call.
This transcript is brought to you by Benzinga APIs. For real-time accessread more...

What to Know About This $476,000 Palvella Therapeutics Insider Sale After a 620% Stock Rally

Key Points4,302 common shares were exercised and sold on June 17, 2026, for $476,000 at a weighted average price of around $110.73 per share...

ResVita Bio Appoints John D. Doux, M.D., M.B.A., to Board of Directors

ResVita Bio Appoints John D. Doux, M.D., M.B.A., to Board of Directors ResVita Bio Appoints John D. Doux, M.D., M.B.A., to Board of Directors PR Newswire BERKELEY, Calif., June 9, 2026 BERKELEY, Calif., June 9, 2026 /PRNewswire/ -- ResVita Bio, a biotechnology company pioneering a topical cell...

Jennison Associates LLC Has $40.56 Million Position in Palvella Therapeutics, Inc. $PVLA

Jennison Associates LLC boosted its position in shares of Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 262.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 387,483 shares of the company's stock after purchasing an additional...

Palvella Therapeutics (PVLA) Expected to Announce Quarterly Earnings on Thursday

Palvella Therapeutics (NASDAQ:PVLA) will be releasing its Q1 2026 earnings before the market opens on Thursday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-7-palvella-therapeutics-stock...

Palvella Therapeutics, Inc. (NASDAQ:PVLA) Given Consensus Recommendation of "Moderate Buy" by Analysts

Palvella Therapeutics, Inc. (NASDAQ:PVLA - Get Free Report) has received an average rating of "Moderate Buy" from the fifteen ratings firms that are presently covering the stock, Marketbeat reports...

Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up - What's Next?

Palvella Therapeutics (NASDAQ:PVLA) Shares Gap Up - Time to Buy...

Deltec Asset Management LLC Has $251,000 Stock Position in Palvella Therapeutics, Inc. $PVLA

Deltec Asset Management LLC decreased its position in Palvella Therapeutics, Inc. (NASDAQ:PVLA - Free Report) by 80.8% in the 4th quarter, according to the company in its most recent filing with the...

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Palvella Therapeutics Inc.

Why Did PVLA Stock Surge 37% Today?

Equity

Bearish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$120.30
Prev Close	$127.34
Open	$127.27
Dividend Yield	0.00%
50-Day Moving Average	$146.14
Beta	1.15
Avg. Volume	212,912.84
PE Ratio	-26.34

52-Week High	$161.38
52-Week Low	$68.96
Market Capitalization	$1.83B
EPS (Annual)	-$3.71
Price to Book	8.45
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

PVLA Fundamentals